A shorter path into personalized longevity care
**Innovative Vitality** has launched a new program, **Longevity Labs & Provider Review**, aimed at bridging the gap between patients' subjective health experien...
significant
Every story
The whole archive, filed by the part of life it belongs to — and labelled with how strong the evidence behind it actually is.
Showing 2065–2088 of 3,535
Global Virus Network Statement on H5N1 Vaccine Developments
**Moderna has initiated a Phase 3 clinical trial for its mRNA-based H5N1 vaccine candidate (mRNA-1018), a significant advancement in addressing the ongoing thre...
A Robust Senescence Response Helps Wounds Heal
A recent study reveals that **robust senescence responses** in younger mice significantly enhance wound healing compared to older mice, who exhibit chronic sene...
significant
8 Ways to Help Protect Your Vision Right Now
The **National Eye Institute** has released a set of eight expert recommendations aimed at preventing age-related eye diseases, emphasizing the importance of co...
University of New England launches new Institute of Public and Planetary Health in honor of philanthropist and IDEXX Founder David Evans Shaw
The University of New England (UNE) has launched the **David Evans Shaw Institute of Public and Planetary Health**, backed by a transformative $5 million donati...
This hidden kind of stress may be damaging your memory as you age
A recent study from Rutgers University highlights the significant role of **internalized stress**—particularly feelings of **hopelessness**—in accelerating memo...
significant
Scientists discover how to freeze transplant organs without cracking them
Researchers at Texas A&M University have made significant strides in the field of organ cryopreservation, addressing a critical challenge: the cracking of tissu...
Backed by Goldman Sachs, Urgent Care Provider Xpress Wellness Appoints New Chief Operating Officer to Support Continued Growth
Xpress Wellness has appointed **Joe Willey** as Chief Operating Officer, effective April 27, 2026. Willey will be responsible for overseeing daily operations ac...
KFSH Joins Milken Institute Global Conference 2026 in Beverly Hills, California, as a Silver Sponsor
King Faisal Specialist Hospital & Research Centre (KFSH) will serve as a Silver Sponsor at the **Milken Institute Global Conference 2026**, where Dr. Björn Zoëg...
WellSpan Behavioral Health Walk-In Crisis Center opens in York
WellSpan Health has launched the **WellSpan Behavioral Health Walk-In Crisis Center** in York, Pennsylvania, providing a critical resource for individuals facin...
Alpha Tau Announces Presentation of Pancreatic Cancer Data at Upcoming ASCO Annual Meeting, Showcasing Combined Results from Three Alpha DaRT Pancreatic Cancer Studies
Alpha Tau Medical Ltd. has achieved a significant milestone with the acceptance of its abstract titled “Combined Safety and Efficacy Results from Three Clinical...
MS Canada Calls on Canadians to Take Action During MS Awareness Month Towards a World Free of MS
**MS Canada is spearheading MS Awareness Month this May, emphasizing the critical need for early and accurate diagnosis of multiple sclerosis (MS). With an alar...
Adial Pharmaceuticals Submits Application to FDA Commissioner’s National Priority Voucher (CNPV) Pilot Program for AD04 Clinical Development Program
Adial Pharmaceuticals has submitted its AD04 product application for the FDA's Commissioner’s National Priority Voucher Pilot Program (CNPV), which aims to expe...
Scientists may have found the brain’s switch for chronic pain
Researchers at the University of Colorado Boulder have identified a critical brain region, the **caudal granular insular cortex (CGIC)**, that functions as a "p...
Erasca to Host Conference Call and Webcast to Discuss Preliminary Phase 1 Dose Escalation Data for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015
Erasca, Inc. has announced preliminary Phase 1 dose escalation data for its investigational pan-RAS molecular glue, **ERAS-0015**, aimed at treating patients wi...
MediPharm Labs Positioned to Serve Growing U.S. Pharmaceutical and Clinical Research Demand Following Cannabis Rescheduling
On April 22, 2026, the U.S. Department of Justice and Drug Enforcement Administration officially rescheduled FDA-approved cannabis drug products and state-licen...
Tenaya Therapeutics Announces Late-Breaking Oral Presentation of New Clinical Data from RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy in Adults with PKP2-Associated ARVC at ASGCT 2026
Tenaya Therapeutics has announced the acceptance of multiple abstracts for presentation at the upcoming ASGCT Annual Meeting, including a late-breaking oral pre...
Arcutis Submits Supplemental New Drug Application to the FDA for ZORYVE® (roflumilast) Cream 0.05% to Expand Indication for Treatment of Atopic Dermatitis to Infants Down to 3 Months
Arcutis Biotherapeutics has submitted a supplemental New Drug Application (sNDA) to the FDA for **ZORYVE® (roflumilast) cream 0.05%**, seeking to extend its use...
PharmAla Executes Binding Letter of Intent for Formation of Special Purpose Vehicle to Develop Patented Novel MDXX Molecule APA-01
PharmAla Biotech Holdings Inc. has entered into a binding letter of intent with Aluvaris Inc. to establish a special purpose vehicle (SPV) aimed at advancing th...
Real-World Data on EXPAREL® Shows Reduced Opioid Use and Lower Total Medical Costs in Medicare Patients Undergoing Total Hip Arthroplasty
Pacira BioSciences, Inc. has unveiled significant findings from a real-world study assessing the impact of **EXPAREL® (bupivacaine liposome injectable suspensio...
HCW Biologics Delivers a Major Update for its T-Cell Engager Program Revealing Mechanism of Action and Validating Tissue Factor as Target for Treatment of Solid Tumors
HCW Biologics has unveiled promising preclinical data on its lead T-Cell Engager, **HCW11-018b**, at the AACR Annual Meeting 2026. This tetra-valent T-cell enga...
Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill
Medicus Pharma Ltd. has initiated a strategic push for regulatory support of its investigational therapy SkinJect® aimed at treating Gorlin Syndrome, a rare gen...
Tovecimig Demonstrates Statistically Significant Benefit in COMPANION-002 Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer
**Compass Therapeutics' recent findings on tovecimig, a bispecific antibody targeting DLL4 and VEGF-A, reveal a significant enhancement in median progression-fr...
Alterity Therapeutics Receives Positive FDA Feedback Following Second Type C Meeting on ATH434 Phase 3 Program in Multiple System Atrophy
Alterity Therapeutics has received positive regulatory feedback from the U.S. FDA regarding its planned Phase 3 development program for **ATH434**, a potential...